Aptevo Therapeutics Inc. Revenue 2015–2022
Aptevo Therapeutics Inc. annual/quarterly revenue history and growth rate from 2015 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Aptevo Therapeutics Inc. revenue for the quarter ending March 31, 2022 was 3.1 M, a 28.62% increase year-over-year.
- Aptevo Therapeutics Inc. revenue for the twelve months ending March 31, 2022 was 11.7 M, a 35.87% decrease year-over-year.
- Aptevo Therapeutics Inc. annual revenue for 2022 was 3.1 M, a 74.67% decrease from 2021.
- Aptevo Therapeutics Inc. annual revenue for 2021 was 12.3 M, a 185.26% increase from 2020.
- Aptevo Therapeutics Inc. annual revenue for 2020 was 4.3 M, a 86.71% decrease from 2019.
- Aptevo Therapeutics Inc. annual revenue for 2019 was 32.4 M.
Aptevo Therapeutics Inc. (APVO) — Frequently Asked Questions
Aptevo Therapeutics Inc. (APVO) is a publicly traded US company. It has a market capitalization of $24M. In fiscal 2022 it reported revenue of $3M and net income of $8M. Explore APVO's stock price, financial statements, earnings history, margins and key ratios below.
What is Aptevo Therapeutics Inc.'s market cap?
Aptevo Therapeutics Inc. (APVO) has a market capitalization of $24M.
What is the APVO stock price?
APVO trades at $4.63 (-1.91% on the day).
How much revenue does Aptevo Therapeutics Inc. make?
Aptevo Therapeutics Inc. reported revenue of $3M in fiscal 2022.
Is APVO profitable?
In fiscal 2022, Aptevo Therapeutics Inc. reported net income of $8M.